Ipca Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

848.15 -15.85 ▼-1.8%

27 January 2023, 04:01:00 PM
Volume: 6,312

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ipca.com
Market Cap 21,596.57 Cr.
Enterprise Value(EV) 21,407.68 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 24.21 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 35.15 Trailing Twelve Months Ending 2022-09
Industry PE 33.61 Trailing Twelve Months Ending 2022-09
Book Value / Share 228.11 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.73 Calculated using Price: 851.00
Dividend Yield 0.47 Period Ending 2022-03
No. of Shares Subscribed 25.37 Cr. 253,704,218 Shares
FaceValue 1
Company Profile
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Ipca Laboratories is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.83%
1 Week
-1.58%
1 Month
-0.92%
3 Month
-8.55%
6 Month
-14.15%
1 Year
-15.79%
2 Year
-12.76%
5 Year
+198.20%
10 Year
+238.47%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 27.22 12.43 4.31 8.60 9.47 15.28 18.15 27.63 17.87
Return on Capital Employed (%) 27.92 13.78 4.82 9.44 9.94 16.53 19.92 30.92 20.41
Return on Assets (%) 16.19 7.38 2.50 5.17 6.03 10.25 12.47 20.29 13.30

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,960 2,208 2,259 2,455 2,689 3,122 3,627 4,702 5,492 5,778
Non Curr. Liab. 459 700 663 548 419 313 290 190 602 652
Curr. Liab. 791 904 970 956 1,008 1,098 1,326 1,161 1,466 1,385
Minority Int. 16 14 15 77 81
Equity & Liab. 3,211 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,637 7,896
Non Curr. Assets 1,609 2,198 2,270 2,218 2,170 2,171 2,402 2,629 3,180 3,342
Curr. Assets 1,601 1,614 1,622 1,742 1,945 2,378 2,856 3,437 4,457 4,554
Misc. Exp. not W/O
Total Assets 3,211 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,637 7,896

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 3,282 3,144 2,867 3,156 3,258 3,746 4,619 5,395 5,797 5,906
Other Income 52 59 41 55 58 75 87 129 122 86
Total Income 3,334 3,203 2,908 3,211 3,316 3,820 4,706 5,524 5,918 5,992
Total Expenditure -2,570 -2,630 -2,593 -2,741 -2,816 -3,067 -3,729 -3,914 -4,539 -4,849
PBIDT 764 573 314 470 500 753 977 1,610 1,379 1,143
Interest -30 -32 -35 -27 -28 -22 -20 -12 -11 -21
Depreciation -103 -180 -163 -173 -178 -182 -211 -209 -232 -245
Taxation -152 -102 -20 -68 -51 -104 -135 -240 -225 -237
Exceptional Items
PAT 478 259 96 203 244 444 611 1,149 911 639
Minority Interest 3 3 -1 -6 -8
Share Associate 0 -5 -3 -8 -4 -2 -8 -8 -21 -18
Other Related Items
Consolidated Net Profit 479 254 93 195 239 446 606 1,140 884 614
Adjusted EPS 19 10 4 8 9 18 24 45 35 20

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 389 522 468 709 282 341 501 570 1,090 856
Cash Fr. Inv. -260 -369 -689 -218 -149 -135 -165 -510 -521 -855
Cash Fr. Finan. -83 -136 251 -462 -159 -130 -183 -137 -306 427
Net Change 46 17 29 29 -26 75 153 -76 264 428
Cash & Cash Eqvt 57 74 104 169 143 218 371 295 559 991

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.29
Public 53.71 53.71 53.71 53.71 53.71 53.71 53.71 53.71 53.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 20 Jan 2023
Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December 2022.
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December 2022.
Fri, 20 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement published in Business Standard and Nav Shakti regarding petition for sanction of Scheme of Amalgamation of Ramdev Chemical Pvt Ltd. and Tonira Exports Ltd. Companys wholly owned subsidiaries with the Company.
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022

Technical Scans View Details >>

Wed, 25 Jan 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Increase in 5 Years High Increase in 5 Years
Closing Near 50 SMA Closing Near 50 SMA
Closing Near 20 SMA Closing Near 20 SMA
CCI Trending Down CCI Trending Down

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Ipca Laboratories Ltd.

What is Ipca Laboratories share price?
Can I buy Ipca Laboratories shares now?
What is the Dividend Yield of Ipca Laboratories?
What is the Market Cap of Ipca Laboratories?
What are the key metrics to analyse Ipca Laboratories?
What is the 52 Week High and Low of Ipca Laboratories?
What is the trend of Ipca Laboratories share price?